No replies to this topic

[JulieMellson]

Bristol-Myers Squibb has announced plans for new state of the art large-scale biologics manufacturing facility in Cruiserath, Dublin 15, approximately $900 million investment. Once completed, the new facility will significantly increase Bristol-Myers Squibb’s biologics manufacturing capacity and play a central role in its global manufacturing network. The site will also serve as the global biological drug product release testing site (GBL).  
 
BMS Cruiserath Biologics is seeking to recruit a permanent QA Manager (Technical). Reporting to the Associate Director Quality Operations, the QA Manager is a key leader and part of the BMS team to add biologics Large Scale Cell Culture (LSCC) manufacturing capacity to the BMS network in Cruiserath, Dublin 15.

The Quality Manager will manage a team to support construction, qualification and validation, technical transfers and commercial operations.

More information: https://express.cand...rd/3ae7b4d30553